Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab

Overview of attention for article published in Annals of Hematology, June 2006

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Device and method for the delivery of drugs for the treatment of posterior segment disease

Application US-9216106-B2

United States of America